Supplementary Table S2. Delivered care for heart failure patients in participating centers according to availability of multidisciplinary care.
| Multidisciplinary Care | |||
|---|---|---|---|
| Not Available (n=23) | Available (n=64) | p-value | |
| BNP dosage | 70% (14/20) | 84% (48/57) | ns |
| Centers with BNP | |||
| Help in the diagnosis | 79% (11/14) | 69% (33/48) | ns |
| Determine the prognosis | 71% (10/14) | 56% (27/48) | ns |
| Help the treatment | 7% (1/14) | 42% (20/48) | 0.023 |
| Monitoring | 57% (8/14) | 60% (29/48) | ns |
| Centers with no BNP | |||
| Lack of access | 83% (5/6) | 89% (8/9) | ns |
| Considered not essential | 16% (1/6) | 22% (2/9) | ns |
| Education program for patient | 6% (1/18) | 42% (22/53) | 0.004 |
| Education program for caregivers | 11% (2/9) | 28% (15/53) | ns |
| Written instructions at hospital discharge | 68% (13/19) | 89% (48/54) | 0.038 |
| By Doctor | 62% (10/11) | 58% (26/45) | ns |
| By Nurse | 38% | 40% | |
| By Others | 0% (0/11) | 2% (1/45) | |
| Patient monitoring programs | 6% (1/16) | 49% (25/51) | 0.001 |
| Using monitoring program | |||
| At ambulatory using non-doctorspecialized monitoring | 0% (0/17) | 26% (13/51) | 0.028 |
| At distance using phone or other method | 6% (1/17) | 24% (9/51) | ns |
| Regular use of HF guidelines | 83% (15/18) | 92% (48/52) | ns |
| DEIC | 61% (11/18) | 38% (20/52) | ns |
| ESC | 5% (1/18) | 19% (10/52) | |
| AHA | 17% (3/18) | 21% (11/52) | |
| Institution's own protocol | 0% (0/18) | 12% (6/52) | |
| Other guidelines | 0% (0/18) | 2% (1/52) | |
| Not following guidelines | 17% (3/18) | 8% (4/52) | |
| Using quality of life questionnaire | 35% (6/17) | 24% (12/50) | ns |
| KCCQ | 3% (1/17) | 3% (3/50) | ns |
| MLHFQ | 29% (5/17) (5 out of 17) | 18% (9/50) (9 out of 50) | ns |
| Other | 0% (0/17) | 4% (2/50) | ns |
| Cardiac rehabilitation | 17% (3/18) | 69% (33/50) | <0.001 |
| Key performance indicators | 40% (6/15) | 55% (26/47) | ns |
| Hospital mortality | 27% (4/15) | 32% (15/47) | ns |
| 6-month mortality | 13% (2/15) | 21% (10/47) | ns |
| 30-day hospitalization after discharge | 13% (2/15) | 38% (18/47) | ns |
| 90-day hospitalization after discharge | 7% (1/15) | 17% (8/47) | ns |
| Hospitalization duration | 7% (1/15) | 30% (14/47) | 0.09 |
| Other | 0% (0/17) | 4% (2/47) | ns |
| Medical decision in hospitalized patient in decompensated HF | |||
| By hospital cardiology team | 76% | 44% | <0.001 |
| By cardiologist who cares for the patient in the outpatient clinic | 18% | 43% | <0.001 |
| By intensive care unit doctors if admitted in intensive care unit | 6% | 13% | 0.023 |
| Beginning of HF treatment | |||
| Cardiologist in hospital | 40% | 38% | ns |
| Cardiologist in ambulatory | 43% | 42% | ns |
| General practitioner | 5% | 11% | 0.078 |
| Intensive care doctor | 6% | 4% | ns |
| Geriatrics | 2% | 2% | ns |
| Others | 4% | 3% | ns |
| Prescribed HF treatment | |||
| ACE-I | 100% (18/18) | 94% (51/54) | ns |
| ARBs | 78% (14/18) | 87% (47/64) | ns |
| Β-blocker | 89% (16/18) | 93% (50/54) | ns |
| Spironolactone | 100% (15/18) | 93% (50/54) | ns |
| Digoxin | 33% (6/18) | 43% (23/54) | ns |
| Diuretics | 78% (14/18) | 91% (49/54) | ns |
| Vasodilators | 55% (10/18) | 52% (28/54) | ns |
| Patients with target doses of medication according guidelines (%) | 45% | 61% | <0.001 |
IQR, interquartile range; Specialized HF care considered (in-hospital or outpatient); HF, heart failure; HF-DMP, Disease Management Program for HF; Centers with at least one multidisciplinary member, centers having at least one of the following professions: cardiology, nursing, physiotherapy and/or physical educator or nutritionist; HF, heart failure; BNP, brain natriuretic peptide; DEIC, Heart Failure Department of the Brazilian Society of Cardiology; ESC, European Society of Cardiology; AHA, American Heart Association; MDP, multidisciplinary program; KCCQ, Kansas City Cardiomyopathy Questionnaire; MLHFQ, Minnesota Living with Heart Failure questionnaire; ACE-I Angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers.